Thrombus causes fluctuations in arterial drug delivery from intravascular stents.

Journal of Controlled Release : Official Journal of the Controlled Release Society
Brinda BalakrishnanE R Edelman

Abstract

Arterial drug concentrations determine local toxicity. As such the emergent safety concerns surrounding drug-eluting stents mandate an investigation of the factors contributing to fluctuations in arterial drug uptake. Drug-eluting stents were implanted into porcine coronary arteries, arterial drug uptake was followed and modeled using 2-dimensional computational drug transport. Arterial drug uptake in vivo occurred faster than predicted by free drug diffusion, thus an alternate, mechanism for rapid transport has been proposed involving carrier-mediated transport. Though there was minimal variation in vivo in release kinetics from stent to stent, arterial drug deposition varied by up to 114% two weeks after stent implantation. The extent of adherent mural thrombus also fluctuated by 113% within 3 days after implantation. The computational drug transport model predicted that focal and diffuse thrombi elevate arterial drug deposition in proportion to the thrombus size by reducing drug washout subsequently increasing local drug availability. Fluctuations in arterial drug uptake are commonly reported. We now explain that variable peristrut thrombus can explain such observations even in the face of a narrow range of drug release from...Continue Reading

Citations

Sep 1, 2012·Biomechanics and Modeling in Mechanobiology·Elena CutrìFrancesco Migliavacca
Jan 16, 2010·Annals of Biomedical Engineering·Barry M O'Connell, Michael T Walsh
Oct 24, 2012·Annals of Biomedical Engineering·Stefano Morlacchi, Francesco Migliavacca
Dec 28, 2012·Annals of Biomedical Engineering·William J DennyMichael T Walsh
May 12, 2010·Circulation·Mercedes BalcellsElazer R Edelman
Mar 11, 2010·Biomedical Engineering Online·Barry M O'ConnellMichael T Walsh
Dec 4, 2009·PloS One·Vijaya B KolachalamaElazer R Edelman
May 21, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Mark WebsterTimothy Watson
Nov 12, 2013·Journal of Biomechanics·William J Denny, Michael T Walsh
Jan 28, 2014·Medical Engineering & Physics·William J Denny, Michael T Walsh
Oct 9, 2013·Biomechanics and Modeling in Mechanobiology·Barry M O'ConnellMichael T Walsh
Jun 12, 2009·Drug Delivery·Hyung Il KimKazuhiko Ishihara
Feb 24, 2012·Journal of Pharmaceutical Sciences·James J KleinedlerTammy R Dugas
May 31, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Abraham R TzafririElazer R Edelman
Nov 21, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Abraham R TzafririElazer R Edelman
Apr 21, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qiongyu GuoPatrick T Mather
Oct 18, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vijaya B KolachalamaElazer R Edelman
Feb 27, 2010·Journal of Biomechanics·Giuseppe VairoFrancesco Migliavacca
Jul 20, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Farhad RikhtegarVartan Kurtcuoglu
Apr 17, 2017·Cardiology Clinics·Ramon A Partida, Robert W Yeh
Aug 3, 2014·Journal of Biomechanical Engineering·Xiaoxiang Zhu, Richard D Braatz
Oct 8, 2021·Computer Methods in Biomechanics and Biomedical Engineering·Akash Pradip Mandal, Prashanta Kumar Mandal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.